Dr. Lori Grover has been appointed Dean of the Pennsylvania College of Optometry at Salus University. Dr. Grover, who previously was Director of the Center for Translational Health Science and an Associate Professor in the Department of Health Solutions at Arizona State University, is highly regarded for her extensive experience in optometric education, clinical care of chronic vision impairment, curricular programming, interprofessional education and clinical research in the areas of low vision and health services research. In conjunction with her new role, Dr. Grover is also serving as a member of the ASCO Board of Directors.
Her 23-year academic career includes numerous accomplishments, such as being among the first faculty members at Johns Hopkins University to complete the leadership training program in the Office of Women in Science and Medicine. She has held faculty appointments in the Department of Ophthalmology at the Johns Hopkins University School of Medicine and the Southern California College of Optometry. Dr. Grover currently serves as a Diplomate of the Public Health and Environmental Vision Section of the American Academy of Optometry.
Also: Salus University investigators are among eight study groups who are using an $8 million grant from the
National Eye Institute of the National Institutes of Health to conduct the Convergence Insufficiency Treatment Trial (CITT). CITT is designed to determine whether the successful treatment of convergence insufficiency leads to improvements in attention and reading skills in children 9 to 14 years old. Dr. Mitchell Scheiman, Interim Dean of Research at Salus University, is the Study Chair, and Dr. Michael Gallaway is the Lead Investigator for the university’s Eye Institute.